FDAnews Drug Daily Bulletin

ADAMS RESPIRATORY SWINGS TO 3Q PROFIT

May 12, 2006
A A

Pharmaceutical company Adams Respiratory Therapeutics Inc. said Thursday that it swung to a third-quarter profit due to the lack of a preferred dividend payment and strong sales of over-the-counter respiratory drug Mucinex.
Business Week